In agreement with the results from our previous study, we found that the PPARGC1A mRNA level was significantly decreased in patients with PD (2.85 ± 3.30 vs. 0.99 ± 1.61, P < 0.001). This evidence concerns the gene PPARGC1A and Parkinson disease.